Core Points - The employee stock ownership plan (ESOP) of Dazhenglin Pharmaceutical Group Co., Ltd. will expire on December 3, 2025 [1][2] - The ESOP was approved at the fourth extraordinary general meeting of shareholders in 2020 and has a duration of 36 months [1] - The board of directors has approved an extension of the ESOP for an additional 12 months, now set to expire on December 3, 2025 [2] Summary of Employee Stock Ownership Plan - The ESOP currently holds 6,572,239 shares, representing 0.58% of the company's total share capital [2] - The company has adhered to market trading rules and regulations during the ESOP period, ensuring no insider trading occurred [2] - Upon expiration of the ESOP, it will terminate automatically, and the management committee will handle the disposal of remaining rights in accordance with relevant regulations [2]
大参林: 大参林医药集团股份有限公司关于2020年员工持股计划存续期即将届满的提示性公告